Core Laboratories (CLB) Other Accumulated Expenses (2022 - 2026)

Core Laboratories' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $17.0 million for Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 86.46% year-over-year to $17.0 million; the TTM figure through Jun 2026 stood at $17.0 million (up 86.46% YoY), while the FY2025 annual figure was $16.7 million, up 104.49% from the prior year.
• Other Accumulated Expenses for Q2 2026 stood at $17.0 million, down from $17.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $17.4 million in Q1 2026, with the low at $7.7 million in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $9.1 million (2024), against an average of $10.6 million.
• The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses slipped 8.48% in 2023, then jumped 104.49% in 2025.
• Core Laboratories' Other Accumulated Expenses stood at $8.4 million in 2022, then fell by 8.48% to $7.7 million in 2023, then advanced by 6.61% to $8.2 million in 2024, then surged by 104.49% to $16.7 million in 2025, then grew by 1.98% to $17.0 million in 2026.
• Business Quant data shows CLB's Other Accumulated Expenses at $17.0 million in Q2 2026, $17.4 million in Q1 2026, and $16.7 million in Q4 2025.